top of page

Insights and News Curated for Life Science Experts by Life Science Experts....

Go back to...
JMG Logo transparent.png
Executive Spotlights

Medtronic to Acquire Contego Medical for $380M Plus Potential Additional Payments to Expand Vascular Treatment Portfolio

23 hours ago
1 min read

Galway, Ireland, November 16, 2026 (PR Newswire) -- Medtronic plc (NYSE: MDT) has announced its intent to acquire Contego Medical, Inc., a privately held medical device company specializing in technologies for carotid artery disease and peripheral thrombectomy, in a transaction valued at $380 million, with potential additional payments following the acquisition. The deal builds on Medtronic's existing relationship with Contego, including an exclusive U.S. distribution agreement established in January 2025 and a minority investment dating back to 2020. The acquisition includes Contego's recently FDA-approved Neuroguard IEP Direct System, a transcarotid artery revascularization system with integrated embolic protection and flow reversal, as well as its Excipio thrombectomy devices for treating peripheral vascular disease.


Read full article here.

 
 
 

Recent Posts

See All

Comments


Life Science Headlines
bottom of page